MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Myomo Total Assets 2011-2026 | MYO
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Myomo
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38.6 M | 42.2 M | 14.6 M | 10.2 M | 20.1 M | 14.7 M | 6.6 M | 8.28 M | 14 M | 1.66 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 42.2 M | 1.66 M | 17.1 M |
Quarterly Total Assets Myomo
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.8 M | 34.1 M | 38.7 M | 40.9 M | 42.2 M | 16.3 M | 16.2 M | 16.5 M | 14.6 M | 17.1 M | 13.3 M | 13.7 M | 10.2 M | 12.2 M | - | 18 M | 20.1 M | 17.5 M | 17.7 M | 20.9 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 8.28 M | 8.28 M | 8.28 M | 8.28 M | 14 M | 14 M | 14 M | 14 M | 1.66 M | 1.66 M | 1.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 42.2 M | 1.66 M | 15.7 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
86.1 M | $ 4.3 | -0.69 % | $ 161 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
720 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
304 M | $ 2.29 | -2.97 % | $ 50.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 11.44 | -2.22 % | $ 324 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.01 | - | $ 17.1 M | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 8.27 | 0.49 % | $ 1.24 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 73.83 | 0.26 % | $ 4.03 B |  Britain |
 |
LENSAR
LNSR
|
71.4 M | $ 6.09 | 2.35 % | $ 72.8 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.46 | 0.17 % | $ 28.6 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 18.37 | -0.33 % | $ 431 M | USA |
 |
MiMedx Group
MDXG
|
343 M | $ 3.62 | 0.28 % | $ 535 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 11.02 | -3.76 % | $ 395 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Pulmonx Corporation
LUNG
|
129 M | $ 1.55 | 0.65 % | $ 63.1 M | USA |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Orthofix Medical
OFIX
|
851 M | $ 10.75 | 3.27 % | $ 426 M |  Curacao |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Profound Medical Corp.
PROF
|
77.5 M | $ 6.83 | -2.01 % | $ 206 M | Canada |
 |
Electromed
ELMD
|
53.8 M | $ 38.22 | -0.93 % | $ 323 M | USA |
 |
Butterfly Network
BFLY
|
297 M | $ 4.47 | -0.22 % | $ 1.1 B | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Sintx Technologies
SINT
|
9.51 M | $ 2.39 | 3.91 % | $ 6.63 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 84.81 | 0.24 % | $ 11.5 B | USA |
 |
Insulet Corporation
PODD
|
3.19 B | $ 154.87 | -1.29 % | $ 10.9 B | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 37.23 | 0.57 % | $ 1.16 B | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 43.84 | -2.01 % | $ 1.29 B | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 89.28 | -0.8 % | $ 3.1 B | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 85.78 | 3.1 % | $ 50.2 B | USA |
 |
TransMedics Group
TMDX
|
1.07 B | $ 68.94 | 0.12 % | $ 2.34 B | USA |